Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Akira Nishijima"'
Autor:
Qian Xi, Hidenori Kage, Miho Ogawa, Asami Matsunaga, Akira Nishijima, Kenbun Sone, Kei Kawana, Katsutoshi Oda
Publikováno v:
Cancers, Vol 16, Iss 1, p 136 (2023)
This study aimed to comprehensively clarify the genomic landscape and its association with tumor mutational burden-high (TMB-H, ≥10 mut/Mb) and microsatellite instability-high (MSI-H) in endometrial, cervical, and ovarian cancers. We obtained genom
Externí odkaz:
https://doaj.org/article/7d1fdb73623044ecb039ecd2817992b8
Autor:
Kenbun Sone, Eri Suzuki, Ayumi Taguchi, Harunori Honjoh, Akira Nishijima, Satoko Eguchi, Yuichiro Miyamoto, Takayuki Iriyama, Mayuyo Mori, Yutaka Osuga
Publikováno v:
Journal of Clinical Medicine, Vol 11, Iss 21, p 6527 (2022)
Positive peritoneal cytology is a poor prognostic factor in patients with advanced endometrial cancer. Suspicious positive peritoneal cytology (class III) is commonly encountered in clinical practice. However, no standard treatment protocol exists fo
Externí odkaz:
https://doaj.org/article/1f590b1212364c4d89fd0109c62c1cdd
Autor:
Juri Ogishima, Ayumi Taguchi, Akira Kawata, Kei Kawana, Mitsuyo Yoshida, Yuki Yoshimatsu, Masakazu Sato, Hiroe Nakamura, Yoshiko Kawata, Akira Nishijima, Asaha Fujimoto, Kensuke Tomio, Katsuyuki Adachi, Takeshi Nagamatsu, Katsutoshi Oda, Tohru Kiyono, Yutaka Osuga, Tomoyuki Fujii
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-13 (2018)
Abstract Background Peritoneal dissemination is a critical prognostic factor in ovarian cancer. Although stabilized spheroid formation promotes cancer cell peritoneal dissemination in ovarian cancer, the associated oncogenes are unknown. In this stud
Externí odkaz:
https://doaj.org/article/6adefcccd1924b75a00a38f27799979f
Autor:
Yukari Kobayashi, Kazuhiro Kakimi, Hirokazu Matsushita, Katsutoshi Oda, Shogo Yamamoto, Kayo Asada, Takahiro Karasaki, Akira Nishijima, Takahide Nejo, Yuji Ikeda, Manami Miyai, Yusuke Takahashi, Rui Yamaguchi, Hiroyuki Aburatani
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 1 (2020)
Background There is increasing evidence for the benefit of poly ADP ribose polymerase (PARP) inhibitors in a subset of high-grade serous ovarian carcinoma (HGSC) patients, especially those with homologous recombination (HR)-deficient tumors. However,
Externí odkaz:
https://doaj.org/article/83da46cfa4344dbd93bfcb670236fb67
Autor:
Hirokazu Matsushita, Kosei Hasegawa, Katsutoshi Oda, Shogo Yamamoto, Akira Nishijima, Yuichi Imai, Kayo Asada, Yuji Ikeda, Takahiro Karasaki, Keiichi Fujiwara, Hiroyuki Aburatani, Kazuhiro Kakimi
Publikováno v:
OncoImmunology, Vol 6, Iss 8 (2017)
Neoantigens derived from tumor-specific somatic mutations are excellent targets for anti-tumor immune responses. In ovarian clear cell carcinoma (OCCC), checkpoint blockade yields durable responses in a subset of patients. To approach the question of
Externí odkaz:
https://doaj.org/article/904bf863f2eb4b7bbd41ffa40ff2d623
Autor:
Airi Komura, Ayumi Taguchi, Masako Ikemura, Akira Nishijima, Yuichiro Miyamoto, Michihiro Tanikawa, Kenbun Sone, Mayuyo Mori, Katsutoshi Oda, Yutaka Osuga
Publikováno v:
Journal of Obstetrics and Gynaecology Research. 49:1300-1304
Autor:
Katsuhiko Nara, Ayumi Taguchi, Takehito Yamamoto, Konan Hara, Yuri Tojima, Harunori Honjoh, Akira Nishijima, Satoko Eguchi, Yuichiro Miyamoto, Kenbun Sone, Mayuyo Mori, Tappei Takada, Yutaka Osuga
Background: Single-agent chemotherapy with or without bevacizumab (Bev) is a standard therapy for platinum-resistant ovarian cancer (PR-OC). However, there is a lack of literature on chemotherapy agent selection in heterogenous PR-OC. Therefore, we a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f4d4a2bf4c245de199a7c6f96f6fe873
https://doi.org/10.21203/rs.3.rs-2759326/v1
https://doi.org/10.21203/rs.3.rs-2759326/v1
Autor:
Futaba, Inoue, Kenbun, Sone, Yusuke, Toyohara, Saki, Tanimoto, Yu, Takahashi, Misako, Kusakabe, Asako, Kukita, Harunori, Honjoh, Akira, Nishijima, Ayumi, Taguchi, Yuichiro, Miyamoto, Michihiro, Tanikawa, Takayuki, Iriyama, Mayuyo-Mori, Uchino, Tetsushi, Tsuruga, Osamu, Wada-Hiraike, Katsutoshi, Oda, Yutaka, Osuga
Publikováno v:
Biochemical and Biophysical Research Communications. 601:123-128
Histone modification is the key epigenetic mechanism that regulates gene expression. Coactivator-associated arginine methyltransferase 1 (CARM1) is an arginine methyltransferase that catalyzes dimethylation of histone H3 (H3R17) at arginine 17. Latel
Autor:
Chihiro Ishizawa, Ayumi Taguchi, Michihiro Tanikawa, Harunori Honjo, Akira Nishijima, Satoko Eguchi, Yuichiro Miyamoto, Kenbun Sone, Tetsushi Tsuruga, Mayuyo Mori, Yutaka Osuga
Publikováno v:
Oncology Letters. 25
Publikováno v:
Personalization in Gynecologic Oncology ISBN: 9789811947100
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d192ff75a58527a7172652575f24d0ea
https://doi.org/10.1007/978-981-19-4711-7_5
https://doi.org/10.1007/978-981-19-4711-7_5